Target intelligence / Profile preview

MT-ND5 pseudogene 24 (MTND5P24)

Target
MTND5P24
Molecular classification
Other (Pseudogene)
01

Overview

MT-ND5 pseudogene 24 is a human nuclear pseudogene derived from mitochondrial DNA, representing a non-functional copy of the MT-ND5 gene. MT-ND5 itself encodes a core subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase) that is crucial for electron transport and ATP synthesis through oxidative phosphorylation[1][3][5][6][7][8]. However, MTND5P24 does not encode a functional protein product; it carries mutations and disruptions that prevent translation into a functional subunit[6]. The designation "pseudogene" indicates the sequence is a genomic relic and not an active molecular target for therapeutics or drug interactions. Variants of the functional MT-ND5 gene are associated with mitochondrial diseases, but the pseudogene MTND5P24 has no established biological or disease function. The name "MT-ND5 pseudogene 24" refers to a nuclear pseudogene, not the active mitochondrial MT-ND5 gene or protein. The active MT-ND5 gene (not the pseudogene) is involved in mitochondrial electron transport, and mutations in the authentic gene are linked to diseases like Leigh syndrome, MELAS, and Leber hereditary optic neuropathy[1][3][5][8]. The pseudogene, however, has no such roles. The query is thus focused on a non-target, and this should be flagged as potentially incorrect for pharmacological or therapeutic target inquiry. MTND5P24 is a non-functional pseudogene, not a valid drug or therapeutic target[6].

Other names
MTND5P24Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 pseudogene 24

Beyond the preview

Go deeper on MT-ND5 pseudogene 24 (MTND5P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MT-ND5 pseudogene 24 (MTND5P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call